Anti-Helicobacter pylori activity of non-living, heat-killed form of lactobacilli including Lactobacillus johnsonii No.1088

FEMS Microbiology Letters

Volumn 364, Issue 11, 2017, Pages

  Aiba, Yuji ^a,b   Ishikawa, Hiroki ^a   Tokunaga, Masayoshi ^b   Komatsu, Yasuhiko ^a  

^a Snowden Co Ltd   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti Helicobacter pylori activity; Germ free mice; Lactic acid bacterium; Lactobacillus johnsonii; Non living heat killed form; Scanning electron microscopy

Indexed keywords

PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL STRUCTURES; BACTERICIDAL ACTIVITY; CELL SURFACE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL INFECTION; HEAT TREATMENT; HELICOBACTER INFECTION; IN VITRO STUDY; INCUBATION TIME; LACTOBACILLUS JOHNSONII; LETTER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; ANIMAL; ANTIBIOSIS; BAGG ALBINO MOUSE; CLASSIFICATION; DISEASE MODEL; GROWTH, DEVELOPMENT AND AGING; HEAT; HELICOBACTER PYLORI; LACTOBACILLUS; MICROBIOLOGY; PHYSIOLOGY; STOMACH;

ANIMALS; ANTIBIOSIS; DISEASE MODELS, ANIMAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOT TEMPERATURE; LACTOBACILLUS; LACTOBACILLUS JOHNSONII; MALE; MICE; MICE, INBRED BALB C; PROBIOTICS; STOMACH;

EID: 85026842550     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1093/femsle/fnx102     Document Type: Letter

References (22)

1. Aiba Y, Nakano Y, Koga Y et al. A highly acid-resistant novel strain of Lactobacillus johnsonii No. 1088 has antibacterial activity, including that against Helicobacter pylori, and inhibits gastrin-mediated acid production in mice. Microbiology Open 2015;4:465-74
2. Boyanova L, Stephanova-Kondratenko M, Mitov I. Anti-Helicobacter pylori activity of Lactobacillus delbrueckii subsp. bulgaricus strains: preliminary report. Lett Appl Microbiol 2009;48:579-84
3. Dang Y, Reinhardt JD, Zhou X et al. The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a meta-analysis. PLoS One 2014;9:e111030
4. Felley CP, Corthesy-Theulaz I, Rivero JL et al. Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur J Gastroenterol Hepatol 2001;13:25-9
5. Fujimura S, Kato S, Oda M et al. Detection of Lactobacillus gasseri OLL2716 strain administered with yogurt drink in gastricmucus layer in humans. Lett Appl Microbiol 2006;43:578-81
6. Fukushima Y, Yamano T, Kusano A et al. Effect of fermentedmilk containing Lactobacillus johnsonii La1 (LC1) on defecation in healthy Japanese adults-A double blind placebo controlled study. Bioscience Microflora 2004;23:139-47
7. Holz C, Busjahn A, Mehling H et al. Significant reduction in Helicobacter pylori load in humans with non-viable Lactobacillus reuteri DSM17648: A pilot study. Probiotics Antimicrob Proteins 2015;7:91-100
8. Kabir AM, Aiba Y, Takagi A et al. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 1997;41:49-55
9. Kato-Mori Y, Orihashi T, Kanai Y et al. Fermentation metabolites from Lactobacillus gasseri and Propionibacterium freudenreichii exert bacteriocidal effects in mice. J Med Food 2010;13: 1460-7
10. Komatsu Y, Aiba Y, Nakano Y et al. Probiotics, prebiotics, and biogenics for the stomach. In: Rao V, Rao LG (eds.) Prebiotics and Probiotics in Human Nutrition and Health. Rijeka, Croatia: InTech, 2016, 363-81
11. Kusters JG, Gerrits MM, Van Strijp JA et al. Coccoid forms of Helicobacter pylori are the morphologic manifestation of cell death. Infect Immun 1997;65:3672-9
12. Lu C, Sang J, He H et al. Probiotic supplementation does not improve eradication rate of Helicobacter pylori infection compared to placebo based on standard therapy: a meta-analysis. Sci Rep 2016;6:23522
13. Malfertheiner P, Megraud F, O'Morain C et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-81
14. Marshall BJ, Armstrong JA, McGechie DB et al. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust 1985;142:436-9
15. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;1:1311-5
16. Michetti P, Dorta G, Wiesel PH et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 1999;60:203-9
17. Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 1987;82:192-9
18. Nishizawa T, Maekawa T, Watanabe N et al. Clarithromycin versus metronidazole as first-line Helicobacter pylori eradication: A multicenter, prospective, randomized controlled study in Japan. J Clin Gastroenterol 2015;49:468-71
19. Peek RM, Jr. Helicobacter pylori strain-specific modulation of gastric mucosal cellular turnover: implications for carcinogenesis. J Gastroenterol 2002;37(Suppl 13):10-6
20. Sakamoto I, Igarashi M, Kimura K et al. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J Antimicrob Chemother 2001;47:709-10
21. Suzuki S, Gotoda T, Kusano C et al. The efficacy and tolerability of a triple therapy containing a potassium-competitive acid blocker compared with a 7-day PPI-based low-dose clarithromycin triple therapy. Am J Gastroenterol 2016;111:949-56
22. Willen R, Carlen B, Wang X et al. Morphologic conversion of Helicobacter pylori from spiral to coccoid form Scanning (SEM) and transmission electron microscopy (TEM) suggest viability. Ups J Med Sci 2000;105:31-40